Mass Spectrometry-based Cancer Biomarker Discovery: Current Pitfalls and Future Perspectives. An Interview with Dr. Eleftherios P. Diamandis

Main Article Content

Azza Eissa



Dr. Eleftherios P. Diamandis is a Professor at the University of Toronto and a researcher in the Samuel Lunenfeld Research Institute of Mount Sinai Hospital. His lab integrates enzymology, cell biology, proteomics and translational research in the pursuit of discovering biomarkers that could aid in early detection and monitoring of cancer and other diseases. With over 25 years of experience in analytical chemistry and clinical biochemistry, Dr. Diamandis is recognized as a leading researcher in the cancer biomarker field. In addition to his Biochemist-in-Chief position at University Health Network, Dr. Diamandis is the Division Head of Clinical Biochemistry at Mount Sinai Hospital and a Professor in the Department of Laboratory Medicine and Pathobiology at University of Toronto.